{
    "2020-12-22": [
        [
            {
                "time": "",
                "original_text": "经营现金流吃紧 毛利率低于同业！达嘉维康遭四轮问询 IPO路坎坷 询问",
                "features": {
                    "keywords": [
                        "经营现金流",
                        "毛利率",
                        "同业",
                        "达嘉维康",
                        "IPO"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "溢价507%收购赤峰人川 大举收购下老百姓毛利净利行业垫底 财务风险逐渐显现",
                "features": {
                    "keywords": [
                        "溢价收购",
                        "赤峰人川",
                        "毛利净利",
                        "行业垫底",
                        "财务风险"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "零售",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "55股融资余额降幅超5%",
                "features": {
                    "keywords": [
                        "融资余额",
                        "降幅超5%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：医保谈判落地不确定性消除 加大医药优质赛道关注度",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "不确定性消除",
                        "优质赛道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：“三重行业红利 五重公司催化”助推智飞生物 强调Q1医药躁动机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业红利",
                        "公司催化",
                        "智飞生物",
                        "Q1医药躁动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块2021年春季行情如何？",
                "features": {
                    "keywords": [
                        "医药板块",
                        "2021年",
                        "春季行情"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}